Document Detail

Outcome of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stent Implantation in Patients With and Without Diabetes Mellitus (a SORT OUT III Substudy).
MedLine Citation:
PMID:  21864817     Owner:  NLM     Status:  Publisher    
Diabetes is associated with an increased risk of major adverse cardiac events after percutaneous coronary intervention. We compared clinical outcomes in patients with and without diabetes mellitus treated with the second-generation Endeavor zotarolimus-eluting stent (ZES) or the first-generation Cypher Select+ sirolimus-eluting stent (SES). We randomized 2,332 patients to treatment with ZESs (n = 1,162, n = 169 diabetics) or SESs (n = 1,170, n = 168 diabetics) and followed them for 18 months. Randomization was stratified by presence/absence of diabetes. The primary end point was major adverse cardiac events defined as a composite of cardiac death, myocardial infarction, or target vessel revascularization. Secondary end points included these individual end points plus all-cause mortality and target lesion revascularization. In diabetic patients, use of ZES compared to SES was associated with an increased risk of major adverse cardiac events (18.3% vs 4.8%, hazard ratio 4.05, 95% confidence interval 1.86 to 8.82), myocardial infarction (4.7% vs 0.6%, hazard ratio 8.09, 95% confidence interval 1.01 to 64.7), target vessel revascularization (14.2% vs 3.0%, hazard ratio 4.99, 95% confidence interval 1.90 to 13.1), and target lesion revascularization (12.4% vs 1.2%, hazard ratio 11.0, 95% confidence interval 2.59 to 47.1). In patients without diabetes differences in absolute risk decrease were smaller but similarly favored SES. In conclusion, implantation of ZESs compared to SESs is associated with a considerable increased risk of adverse events in patients with diabetes at 18-month follow-up.
Michael Maeng; Lisette O Jensen; Hans-Henrik Tilsted; Anne Kaltoft; Henning Kelbaek; Ulrik Abildgaard; Anton Villadsen; Jens Aarøe; Per Thayssen; Lars R Krusell; Evald H Christiansen; Hans E Bøtker; Steen D Kristensen; Jan Ravkilde; Morten Madsen; Henrik T Sørensen; Klaus Rasmussen; Leif Thuesen; Jens F Lassen
Related Documents :
3234637 - Polymerisation and crosslinking of fibrin monomers in diabetes mellitus.
18379827 - Application of two component biodegradable carriers in a particle-fixed biofilm airlift...
23641007 - Diabetes and vascular disease: pathophysiology, clinical consequences, and medical ther...
3311187 - The self-association of zinc-free bovine insulin. a single model based on interactions ...
7485007 - Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis.
22219517 - Pilot study of resveratrol in older adults with impaired glucose tolerance.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-23
Journal Detail:
Title:  The American journal of cardiology     Volume:  -     ISSN:  1879-1913     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of Smoking on Outcomes of Patients With ST-Segment Elevation Myocardial Infarction (from the ...
Next Document:  Relation Between Left Ventricular Morphology and Reduction in Functional Mitral Regurgitation by Car...